Baudax Bio Inc (BXRX)

1.6500 -0.0500 (-2.94%)
Real-time Cboe USD Disclaimer

Baudax Bio Inc Company Profile

Equity Type
Baudax Bio, Inc. is a pharmaceutical company. The Company is primarily focused on commercializing and developing products for hospital and related acute care settings. The Company's lead product candidate is ANJESO (meloxicam) injection. ANJESO is a preferential COX-2 inhibitor that possesses analgesic, anti-inflammatory, and antipyretic activities. This injectable form of IV meloxicam, utilizes NanoCrystal technology, increases overall drug solubility that provides a faster onset of action of meloxicam and provides a rapid treatment of acute pain, which lasts for approximately 24 hours. Its pipeline of other pharmaceutical products includes two neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent, which are used as muscle paralyzing agents to facilitate intubation and surgery. The Company has completed Phase III clinical trials.
Contact Information
Malvern,19355 United States
484 395 2440
484 395 2471
Top Executives
William L. Ashton 70 2019 Independent Director
Geraldine A. Henwood 69 2019 President, CEO & Director
Arnold M. Baskies 73 2020 Independent Director
Wayne B. Weisman 66 2019 Independent Chairman
Winston J. Churchill 82 2019 Independent Director
Andrew T. Drechsler 50 2020 Independent Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.